MVA-BN MPox/Smallpox

About Bavarian Nordic

Bavarian Nordic's mission is to protect public health through innovative immunization strategies, establishing itself as a critical player with a dual-revenue model. The company has achieved significant commercial success with its travel health portfolio and solidified its public health role through long-standing government contracts for its non-replicating smallpox/mpox vaccine. Its strategy centers on leveraging its integrated capabilities and MVA platform to expand its commercial portfolio and respond to emerging infectious disease threats, driving sustainable growth.

Therapeutic Areas